Scarica l'app Stockscreener
12.40
1.35%
-0.17
Precedente Chiudi:
$12.57
Aprire:
$12.58
Volume 24 ore:
26,006
Relative Volume:
0.50
Capitalizzazione di mercato:
$272.72M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+3.25%
1M Prestazione:
-10.92%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$11.55
$13.24
Intervallo di 1 settimana:
$11.50
$13.63
Portata 52W:
$4.88
$19.58
Aardvark Therapeutics Inc Stock (AARD) Company Profile
Nome
Aardvark Therapeutics Inc
Settore
Industria
Telefono
(858) 225-7696
Indirizzo
4370 LA JOLLA VILLAGE DRIVE, SAN DIEGO
Confronta AARD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AARD
Aardvark Therapeutics Inc
|
12.57 | 272.19M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.99 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.05 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
427.60 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
668.59 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
294.90 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Aardvark Therapeutics Inc Stock (AARD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2025-03-10 | Iniziato | BofA Securities | Buy |
| 2025-03-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-03-10 | Iniziato | Morgan Stanley | Overweight |
| 2025-03-10 | Iniziato | RBC Capital Mkts | Outperform |
Aardvark Therapeutics Inc Borsa (AARD) Ultime notizie
Is Aardvark Therapeutics Inc. meeting your algorithmic filter criteriaEquity Performance Forecast Based on AI Models - Newser
Technical signs of recovery in Aardvark Therapeutics Inc.Free Accurate Technical Trend Reversal Picks - Newser
Moving Average Trends for Aardvark Therapeutics Inc. Stock: What They IndicateFree Community Verified Stock Suggestions - Newser
Can machine learning forecast Aardvark Therapeutics Inc. recoveryFree Proven Entry Plan With Low Risk Trade - Newser
Why Aardvark Therapeutics Inc. stock is on top investor watchlistsFree Triple Digit Return Stock Predictions - Newser
Published on: 2025-08-05 19:48:37 - Newser
News impact scoring models applied to Aardvark Therapeutics Inc.Free Fundamental + Technical Hybrid Stock Tips - Newser
Aardvark Therapeutics, Inc.’s (NASDAQ:AARD) Lock-Up Period Set To Expire on August 12th - Defense World
Combining price and volume data for Aardvark Therapeutics Inc.Free Capital Preserving Trade Plan Templates - Newser
Volume spikes in Aardvark Therapeutics Inc. stock – what they meanFree Quick Gain Stock Watch With Indicators - Newser
Why Aardvark Therapeutics Inc. stock attracts strong analyst attentionShort Term Gain Strategy with AI Logic - Newser
What analysts say about Aardvark Therapeutics Inc. stockBuild wealth steadily with smart trading - Jammu Links News
Evaluating Aardvark Therapeutics Inc. with trendline analysisWealth Accumulation Outlook for Safe Investors - Newser
Why is Aardvark Therapeutics Inc. stock attracting strong analyst attentionUnlock daily market insights for better decisions - Jammu Links News
Applying big data sentiment scoring on Aardvark Therapeutics Inc.Risk-Managed Trade Alerts for Consistency - newser.com
What are the latest earnings results for Aardvark Therapeutics Inc.Consistent double returns - Jammu Links News
Risk vs reward if holding onto Aardvark Therapeutics Inc.High Conviction Stock Long-Term Summary - newser.com
Is Aardvark Therapeutics Inc. a good long term investmentInvest smarter with data-backed insights - Jammu Links News
How does Aardvark Therapeutics Inc. compare to its industry peersBuild a portfolio that outperforms the market - Jammu Links News
How does Aardvark Therapeutics Inc. generate profit in a changing economyDiscover investment plans that deliver results - Jammu Links News
What makes Aardvark Therapeutics Inc. stock price move sharplyAchieve breakthrough financial results - Jammu Links News
What are analysts’ price targets for Aardvark Therapeutics Inc. in the next 12 monthsUnmatched profit potential - Jammu Links News
Published on: 2025-08-03 04:04:58 - Jammu Links News
Reversal indicators forming on Aardvark Therapeutics Inc. stockSmart Stock Forecast Using AI Algorithms - Newser
Strategies to average down on Aardvark Therapeutics Inc.Free Risk-Adjusted Picks With Exit Strategy - Newser
Earnings visualization tools for Aardvark Therapeutics Inc.Daily Pick Forecast with Entry Zones - Newser
What’s next for Aardvark Therapeutics Inc. stock priceEarnings Impact and Stock Reaction Analysis - Newser
Sector ETF performance correlation with Aardvark Therapeutics Inc.Breakout Entry Signal Confirmation Tool Used - metal.it
Published on: 2025-07-30 23:36:06 - Newser
Aardvark Therapeutics Inc Azioni (AARD) Dati Finanziari
Non sono disponibili dati finanziari per Aardvark Therapeutics Inc (AARD). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Aardvark Therapeutics Inc Azioni (AARD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lee Tien-Li | Chief Executive Officer |
Feb 14 '25 |
Buy |
16.00 |
16,542 |
264,672 |
1,496,175 |
| Sun Nelson | Chief Financial Officer |
Feb 14 '25 |
Buy |
16.00 |
10,000 |
160,000 |
99,484 |
| Cormorant Asset Management, LP | Former 10% Owner |
Feb 14 '25 |
Buy |
16.00 |
187,500 |
3,000,000 |
987,689 |
0.53%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):